Atossa Therapeutics annual revenue
2011
2012
2013
2014
2015
2022
2023
2024
2025
Atossa Therapeutics Revenue Growth & History (ATOS)
Atossa Therapeutics reported $0 in revenue for fiscal 2025.
View full Atossa Therapeutics company overviewAtossa Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | — | — |
| 2015 | 2015-12-31 | $1,758 | −$38,380 | −95.62% |
| 2014 | 2014-12-31 | $40,138 | −$592,420 | −93.65% |
| 2013 | 2013-12-31 | $632,558 | $150,716 | +31.28% |
| 2012 | 2012-12-31 | $481,842 | $480,342 | +32022.80% |
| 2011 | 2011-12-31 | $1,500 | — | — |
Atossa Therapeutics quarterly revenue
Q3.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | — | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q3 2016 | 2016-09-30 | $0 | $0 | — |
| Q2 2016 | 2016-06-30 | $0 | $0 | — |
| Q1 2016 | 2016-03-31 | $0 | $0 | — |
| Q4 2015 | 2015-12-31 | $1,758 | −$955 | −35.20% |
| Q3 2015 | 2015-09-30 | $0 | −$3,426 | −100.00% |
| Q2 2015 | 2015-06-30 | $0 | −$9,875 | −100.00% |
| Q1 2015 | 2015-03-31 | $0 | −$24,124 | −100.00% |
| Q4 2014 | 2014-12-31 | $2,713 | −$44,500 | −94.25% |
| Q3 2014 | 2014-09-30 | $3,426 | −$73,171 | −95.53% |
| Q2 2014 | 2014-06-30 | $9,875 | −$316,203 | −96.97% |
| Q1 2014 | 2014-03-31 | $24,124 | −$158,546 | −86.79% |
| Q4 2013 | 2013-12-31 | $47,213 | −$51,243 | −52.05% |
| Q3 2013 | 2013-09-30 | $76,597 | −$28,979 | −27.45% |
| Q2 2013 | 2013-06-30 | $326,078 | $102,981 | +46.16% |
| Q1 2013 | 2013-03-31 | $182,670 | $127,957 | +233.87% |
| Q4 2012 | 2012-12-31 | $98,456 | — | — |
| Q3 2012 | 2012-09-30 | $105,576 | $105,576 | — |
| Q2 2012 | 2012-06-30 | $223,097 | — | — |
| Q1 2012 | 2012-03-31 | $54,713 | — | — |
| Q3 2011 | 2011-09-30 | $0 | — | — |
Atossa Therapeutics revenue growth trends
Atossa Therapeutics's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Atossa Therapeutics source filings ↗